SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 123 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $743,947 | -29.7% | 51,236 | +1.3% | 0.01% | -33.3% |
| Q2 2023 | $1,058,744 | +11.2% | 50,585 | +12.2% | 0.01% | +12.5% |
| Q1 2023 | $952,280 | -17.6% | 45,089 | -0.7% | 0.01% | -20.0% |
| Q4 2022 | $1,155,583 | +55.9% | 45,406 | +47.2% | 0.01% | +42.9% |
| Q3 2022 | $741,000 | +15.4% | 30,852 | -7.5% | 0.01% | +16.7% |
| Q2 2022 | $642,000 | -34.7% | 33,356 | -41.0% | 0.01% | -45.5% |
| Q1 2022 | $983,000 | -22.8% | 56,536 | -2.8% | 0.01% | -21.4% |
| Q4 2021 | $1,274,000 | +11.9% | 58,179 | -2.4% | 0.01% | +27.3% |
| Q3 2021 | $1,139,000 | +4.4% | 59,593 | -6.2% | 0.01% | +10.0% |
| Q2 2021 | $1,091,000 | +226.6% | 63,541 | +53.7% | 0.01% | +400.0% |
| Q3 2018 | $334,000 | +32.5% | 41,328 | +15.3% | 0.00% | 0.0% |
| Q2 2018 | $252,000 | -45.8% | 35,851 | +9.6% | 0.00% | -50.0% |
| Q1 2018 | $465,000 | +96.2% | 32,712 | +21.0% | 0.00% | +100.0% |
| Q4 2017 | $237,000 | -7.4% | 27,026 | +23.5% | 0.00% | 0.0% |
| Q3 2017 | $256,000 | -7.6% | 21,883 | +10.2% | 0.00% | 0.0% |
| Q2 2017 | $277,000 | -19.5% | 19,853 | -12.4% | 0.00% | -33.3% |
| Q3 2016 | $344,000 | +39.8% | 22,669 | -9.2% | 0.00% | +50.0% |
| Q2 2016 | $246,000 | – | 24,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |